Safety and Efficacy of Andecaliximab in Participants With Moderately to Severely Active Crohn's Disease
Clinical trial NCT02405442 · TERMINATED
Trial details
- NCT number
- NCT02405442
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-30
- Primary completion
- 2016-11-30
- Enrollment
- 187
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.